翻訳と辞書 |
Cantuzumab mertansine : ウィキペディア英語版 | Cantuzumab mertansine
Cantuzumab mertansine (SB-408075; huC242-DM1) is an antibody-drug conjugate used to treat colorectal cancer and other types of cancer.〔(Statement On A Nonproprietary Name Adopted By The Usan Council - Cantuzumab mertansine ), ''American Medical Association''.〕 It is a humanized monoclonal antibody, cantuzumab (huC242) linked to a cytotoxic agent, mertansine (DM1).〔(Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study. Rodon et al. 2008 )〕 ==Mechanism== After the huC242 mab binds to the external domain of CanAg, the cantuzumab mertansine-CanAg complex is internalized, and the DM1 molecules are released intracellularly by cleavage of the DM1-huC242 disulfide bonds.〔(A Phase I Study of Cantuzumab Mertansine Administered as a Single Intravenous Infusion Once Weekly in Patients with Advanced Solid Tumors. Helft et al. 2004 )〕
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Cantuzumab mertansine」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|